Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines

ABSTRACT: The aim of this study is to demonstrate the medical and financial benefit of pre-therapeutic screening of DPD deficiency for predicting toxicity to fluoropyrimidines.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Intravenous 5 Fluorouracile

PROVIDER: 2121491 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR